Message Image

Skip main navigation (Press Enter).

ISCT has a vision to translate cell & gene therapies into safe and effective treatments to improve patients' lives.

ISCT 2025 NEW ORLEANS →

ISCT PEER-REVIEWED JOURNAL →

WORKFORCE DEVELOPMENT →

News from ISCT

ISCT Announces Dr. Phil Vanek as next Chief Commercialization Officer

Jan 30, 2025 06:00

Blog Entry
ISCT Hails Landmark US FDA Approval of RYONCIL® as Major Milestone for MSC Field

Dec 20, 2024 11:14

Blog Entry
Ninth Circuit Decision Marks Critical Legal Victory for U.S. FDA in Mission to Protect Patients from ...

Oct 03, 2024 21:00

Blog Entry
ISCT Celebrates Recent FDA Accelerated Approval of Tecelra: A Landmark Gene Therapy for Metastatic Synovial ...

Aug 14, 2024 14:37

Blog Entry
Committee Spotlight: ISCT Asia Regional Executive Committee

Aug 13, 2024 16:52

Blog Entry

Go to News

Featured Events

Friday

30

May

How to Prepare Your TGA Clinical Trial Application for First in Human CGTs in Australia

Webinar

May 30, 10:30 - 12:00 (ET)
Thursday

5

June

Clinical Impact Forum CAR-T Cells for Autoimmune Diseases

Webinar

Jun 5, 10:00 - 11:30 (PT)
Monday

16

June

Progress in Advanced Cellular and Gene Therapies in South Africa

Webinar

Jun 16, 09:00 - 10:00 (PT)
Wednesday

13

August

ISCT ANZ 2025 Sydney

Regional Event

Aug 13 - 15, (ET)

Manly, NSW, Australia
Monday

8

September

Sept 2025 Workforce Development in Biomanufacturing – Advanced Hands-On Training Course

Event

Sep 8 - 12, (ET)
Thursday

11

September

ISCT-KSBMT Joint Session at ICBMT 2025

Event

Sep 11 - 13, (KST)

Go to Events

Social Media

Follow us on X
@ISCTglobal
4,7K+ followers

Follow us on LinkedIn
@ISCTglobal
14K+ followers

Powered by Higher Logic